Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverRGEN
HealthcareNMSUSD

Repligen Corporation

$001234567890012345678900123456789.0012345678900123456789-7.8%
52w low $100.99$198.87 52w high
Market data · updated 5h ago
Market data
Market cap
$8.17B
52w range
$100.99 - $198.87
Beta
1.06
Sector
Healthcare
Data quality
96/100
Valuation
P/E ratio
159.2x
Forward P/E
56.9x
PEG ratio
2.28
Quality & efficiency
Moat score
55/100
Return on equity
2.5%
Profit margin
6.7%
Debt / equity
0.33
Growth & analysts
Revenue growth
+14.8%
Analyst target
$177.05
Target upside
-0.1%
Analysts
20
Run the 10-point checklist before you buy How these numbers are made

About Repligen Corporation

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Valuation

ValueGrowthProfitHealthIncome32QUALITY
Overall Rating
33
Low quality
Low quality

Derived from filed metrics · High confidence (96% of the inputs available)

Moat Score55
Fair value estimate
Not covered by our valuation model yet.

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$8.17B
P/E Ratio
159.2
Dividend Yield
0.00%
Revenue Growth
+14.8%
Profit Margin
6.7%
ROE
2.5%
Debt / Equity
0.33
Beta
1.06

Statistics

Similar Stocks · Healthcare

Latest News · RGEN